Cyclerion

Cyclerion is a clinical-stage biopharmaceutical company dedicated to discovering, developing, and commercializing innovative medicines for patients with serious central nervous system (CNS) diseases. Cyclerion was founded with the goal of unlocking the full therapeutic potential of the nitric oxide-cyclic guanosine monophosphate (cGMP) signaling pathway.